Trust Point’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Trust Point's PFE Position: Q3 2026 in Review
Trust Point increased its Pfizer (PFE) stake by 12% in Q3 2026, buying an estimated $207K and bringing the position to 75,482 shares worth $2.15M. The position accounts for 0.16% of the portfolio, ranked #80.
Trust Point first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Trust Point held 75,482 shares of Pfizer worth $2.15M as of Q3 2026.
- Trust Point bought 7,799 Pfizer shares in Q3 2026, an estimated $207K.
- Pfizer made up 0.16% of Trust Point's portfolio in Q3 2026, its #80 holding.
- Trust Point first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.